Linked e-resources
Details
Table of Contents
Kety, S.S. Introduction.
Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.
Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.
Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.
Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.
Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.
Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.
Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.
Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.
Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.
Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?
Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.
Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.
Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.
Roth, M. et al. The relationship between classification and response to drugs in affective disorders
problems posed by drug response in affective disorders.
Sandler, M. Variations in monoamine oxidase activity in some human disease states.
Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis.
Tipton, K. F., Houslay, M.D., and Mantle, T.J. The nature and locations of the multiple forms of monamine oxidase.
Maycock, A.L. et al. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: structure of the flavin site in the inhibited enzyme.
Salach, J.I. et al. Cysteinyl flavin in monamine oxidase from the central nervous system.
Gorkin, V.Z. Monoamine oxidase inhibitors and the transformation of monoamine oxidases.
Sourkes, T.L. and Missala, K. Nutritional requirements for amine metabolism in vivo.
Youdim, M.B.H. and Holzbauer, M. Physiological aspects of the oxidative deamination of monoamines.
Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors.
Neff, N.H. and Fuentes, J.A. The use of selective monoamine oxidase inhibitor drugs for evaluating pharmacological and physiological mechanisms.
Trendelenburg, U., Graefe, K.H., and Henseling, M. The part played by monoamine oxidase in the inactivation of catecholamines in intact tissues.
Sharman, D.F. Can the intra- and extra-homoneuronal metabolism of catecholamines be distinguished in the mammalian central nervous system?
Green, A.R. and Youdim, M.B.H. Use of a behavioural model to study the action of monoamine oxidase inhibition in vivo.
Maitre, L., Delini-Stula, A., and Waldmeier, P.C. Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats.
Pare, C.M.B. Introduction to clinical aspects of monoamine oxidase inhibitors in the treatment of depression.
Roth, M. et al. The relationship between classification and response to drugs in affective disorders
problems posed by drug response in affective disorders.
Sandler, M. Variations in monoamine oxidase activity in some human disease states.
Murphy, D.L. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase activity in schizophrenia and schizo-affective psychosis.